Jss Medical Research Asia Pacific Profile
Key Indicators
- Authorised Capital ₹ 15.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 14.49 Cr
as on 16-11-2024
- Company Age 25 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.13 Cr
as on 16-11-2024
- Satisfied Charges ₹ 6.09 Cr
as on 16-11-2024
- Revenue 6.51%
(FY 2023)
- Profit 132.17%
(FY 2023)
- Ebitda 36.50%
(FY 2023)
- Net Worth 43.30%
(FY 2023)
- Total Assets -4.36%
(FY 2023)
About Jss Medical Research Asia Pacific
The Corporate was formerly known as Neeman Medical International (Asia) Limited.. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 14.49 Cr.
The company currently has active open charges totaling ₹1.13 Cr. The company has closed loans amounting to ₹6.09 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Jss Medical Research Asia Pacific Private Limited India are Kishor Kumar as CFO and Kanhaiya Sharma as Company Secretary. Kishor Kumar, Ajoy Kumar, Badri Bandaru, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999HR1999PTC073181
- Company No.
073181
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Oct 1999
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Faridabad, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Jss Medical Research Asia Pacific?
Executive Team (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kishor Kumar | CFO | 03-May-2023 | Current |
Kanhaiya Sharma | Company Secretary | 20-Apr-2022 | Current |
Board Members(4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kishor Kumar | Director | 24-Nov-2015 | Current |
Ajoy Kumar | Director | 28-Nov-2016 | Current |
Badri Bandaru | Director | 11-Jan-2024 | Current |
Eli Mordechai | Director | 02-May-2023 | Current |
Financial Performance and Corporate Structure Insights of Jss Medical Research Asia Pacific.
Jss Medical Research Asia Pacific Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.51% increase. The company also saw a substantial improvement in profitability, with a 132.17% increase in profit. The company's net worth Soared by an impressive increase of 43.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Jss Medical Research Asia Pacific?
In 2023, Jss Medical Research Asia Pacific had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 28 Mar 2024 | ₹4.00 M | Open |
Others Creation Date: 28 Mar 2024 | ₹1.80 M | Open |
Others Creation Date: 01 Nov 2019 | ₹5.50 M | Open |
How Many Employees Work at Jss Medical Research Asia Pacific?
Jss Medical Research Asia Pacific has a workforce of 239 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jss Medical Research Asia Pacific, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jss Medical Research Asia Pacific's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.